Description
This report studies Therapeutic Vaccines in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Therapeutic Vaccines in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.
On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.
Split by product types, covering
Peptide therapeutic vaccine
Cell therapeutic vaccine
Nucleic acid therapeutic vaccine
On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Therapeutic Vaccines, revenue and market share, for key manufacturers.
Top players, covering
Northwest Biotherapeutics
Antigenics
Vaccinogen
CIMAB S.A.
Dendreon
Corixa
AVAX
On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Therapeutic Vaccines in North America, Japan, Europe, India, Southeast Asia and China.
Split by Regions, covering
North America
Europe
Japan
China
India
Southeast Asia
On basis of segments by applications, this report focuses on consumption and growth rate of Therapeutic Vaccines in major applications.
Split by applications, covering
Melanoma
Brain cancer
Kidney Cancer
Others
With 136 pages, 168 charts and eight chapters, to display the market present situation and future, clearly and deeply.
Table of contents
Table of Contents
Global and China Therapeutic Vaccines Research Report to 2020
1 Therapeutic Vaccines Overview and Each Type
 1.1 Product Overview of Therapeutic Vaccines
    1.1.1 Definition and Product Scope of Therapeutic Vaccines
    1.1.2 Global Market Size (Value and Volume) of Therapeutic Vaccines 2015-2020
    1.1.3 China Market Size (Value and Volume) of Therapeutic Vaccines 2015-2020
 1.2 Product Segments and Price of Each Type
    1.2.1 Product Type of Key Manufacturers
    1.2.2 Price List of Each Cell therapeutic vaccine015 to 2016
    1.2.3 Market Share and Growth Rate of Each Type
    1.2.4 Peptide therapeutic vaccine Price and Specification
    1.2.5 Cell therapeutic vaccine Price and and Specification
    1.2.6 Nucleic acid therapeutic vaccine Price and and Specification
 1.3 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
    1.3.1 Price List (Interviewed) of Peptide therapeutic vaccine by Key Manufacturers
    1.3.2 Price List (Interviewed) of Cell therapeutic vaccine by Key Manufacturers
    1.3.3 Price List (Interviewed) of Nucleic acid therapeutic vaccine by Key Manufacturers
2 Competition Analysis by Manufacturers in Global and China
 2.1 Global Market Therapeutic Vaccines Sales and Share List of Key Manufacturers 2015 to 2016
 2.2 Global Market Therapeutic Vaccines Revenue and Share List of Key Manufacturers 2015 to 2016
 2.3 Global Therapeutic Vaccines Average Price List of Key Manufacturers 2015 to 2016
 2.4 China Market Therapeutic Vaccines Sales and Share List of Key Manufacturers 2015 to 2016
 2.5 China Market Therapeutic Vaccines Revenue and Share List of Key Manufacturers 2015 to 2016
 2.6 China Therapeutic Vaccines Average Price List of Key Manufacturers 2015 to 2016
3 Sales and Revenue Segments of Each Cell therapeutic vaccine015 to 2016
 3.1 Global Sales and Revenue Segments of Each Cell therapeutic vaccine015 to 2016
    3.1.1 Global Sales and Market Share of Each Cell therapeutic vaccine015 to 2016
    3.1.2 Global Revenue and Market Share of Each Cell therapeutic vaccine015 to 2016
 3.2 Peptide therapeutic vaccine Sales and Growth Rate 2015 to 2020
 3.3 Cell therapeutic vaccine Sales and Growth Rate 2015 to 2020
 3.4 Nucleic acid therapeutic vaccine Sales and Growth Rate 2015 to 2020
4 Market Segments and Forecast of Therapeutic Vaccines by Regions
 4.1 Sales (Consumption) and Forecast of Therapeutic Vaccines by Regions 2015-2020
    4.1.1 Sales and Forecast of Therapeutic Vaccines by Regions 2015-2020
    4.1.2 Sales Growth Rate Forecast of Therapeutic Vaccines by Regions 2015 to 2020
 4.2 Production and Forecast of Therapeutic Vaccines by Regions 2015 to 2020
    4.2.1 Production and Forecast of Therapeutic Vaccines by Regions 2015 to 2020
    4.2.2 Production Growth Rate Forecast of Therapeutic Vaccines by Regions 2015 to 2020
 4.3 North America Market Forecast to 2020
    4.3.1 North America Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
 4.4 Europe Market Forecast to 2020
    4.4.1 Europe Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
 4.5 Japan Market Forecast to 2020
    4.5.1 Japan Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
 4.6 India Market Forecast to 2020
    4.6.1 India Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
 4.7 Southeast Asia Market Forecast to 2020
    4.7.1 Southeast Asia Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
 4.8 China Market Forecast to 2020
    4.8.1 China Sales (Consumption), Production, Import and Export of Therapeutic Vaccines 2015 to 2020
5 Raw Materials and Applications
 5.1 Key Raw Materials and Price Analysis
    5.1.1 Key Raw Materials and Suppliers Used for Manufacturing Therapeutic Vaccines
    5.1.2 Price Forecast of Key Raw Materials Used for Manufacturing Therapeutic Vaccines 2015 to 2020
    5.1.3 Cost Structure for Manufacturing Therapeutic Vaccines
 5.2 Applications and Price Scope Interviewed in Major Applications
    5.2.1 Price Scope (Interviewed Price to Buyers) of Therapeutic Vaccines in Major Applications 2015 and 2016
    5.2.2 Consumption and Forecast of Therapeutic Vaccines in Major Applications 2015 to 2020
    5.2.2 Consumption Growth Rate Forecast of Therapeutic Vaccines in Major Applications 2015 to 2020
    5.3.3 Consumption Market Share of Therapeutic Vaccines in Major Applications 2015 to 2020
 5.3 Melanoma
    5.3.1 Melanoma Analysis
    5.3.2 Key Consumers (Buyers) and Contact of Therapeutic Vaccines in Melanoma
 5.4 Brain cancer
    5.4.1 Brain cancer Analysis
    5.4.2 Key Consumers (Buyers) and Contact of Therapeutic Vaccines in Brain cancer
 5.5 Kidney Cancer
    5.5.1 Kidney Cancer Analysis
    5.5.2 Key Consumers (Buyers) and Contact of Therapeutic Vaccines in Kidney Cancer
6 Key Manufacturers Analysis of Therapeutic Vaccines
 6.1 Northwest Biotherapeutics
    6.1.1 Company Basic Information
    6.1.2 Therapeutic Vaccines Product Segment of Northwest Biotherapeutics by Type
        6.1.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.1.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.1.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.1.3 Therapeutic Vaccines Sales, Revenue, Price of Northwest Biotherapeutics 2015 to 2016
    6.1.4 Interviewee, Name and Contact
 6.2 Antigenics
    6.2.1 Company Basic Information
    6.2.2 Therapeutic Vaccines Product Segment of Antigenics by Type
        6.2.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.2.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.2.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.2.3 Therapeutic Vaccines Sales, Revenue, Price of Antigenics 2015 to 2016
    6.2.4 Interviewee, Name and Contact
 6.3 Vaccinogen
    6.3.1 Company Basic Information
    6.3.2 Therapeutic Vaccines Product Segment of Vaccinogen by Type
        6.3.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.3.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.3.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.3.3 Therapeutic Vaccines Sales, Revenue, Price of Vaccinogen 2015 to 2016
    6.3.4 Interviewee, Name and Contact
        6.4 CIMAB S.A.
    6.4.1 Company Basic Information
                6.4.2 Therapeutic Vaccines Product Segment of CIMAB S.A. by Type
        6.4.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.4.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.4.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
                6.4.3 Therapeutic Vaccines Sales, Revenue, Price of CIMAB S.A. 2015 to 2016
    6.4.4 Interviewee, Name and Contact
 6.5 Dendreon
    6.5.1 Company Basic Information
    6.5.2 Therapeutic Vaccines Product Segment of Dendreon by Type
        6.5.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.5.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.5.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.5.3 Therapeutic Vaccines Sales, Revenue, Price of Dendreon 2015 to 2016
    6.5.4 Interviewee, Name and Contact
 6.6 Corixa
    6.6.1 Company Basic Information
    6.6.2 Therapeutic Vaccines Product Segment of Corixa by Type
        6.6.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.6.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.6.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.6.3 Therapeutic Vaccines Sales, Revenue, Price of Corixa 2015 to 2016
    6.6.4 Interviewee, Name and Contact
 6.7 AVAX
    6.7.1 Company Basic Information
    6.7.2 Therapeutic Vaccines Product Segment of AVAX by Type
        6.7.2.1 Peptide therapeutic vaccine and Price in 2015 and 2016
        6.7.2.2 Cell therapeutic vaccine and Price in 2015 and 2016
        6.7.2.3 Nucleic acid therapeutic vaccine and Price in 2015 and 2016
    6.7.3 Therapeutic Vaccines Sales, Revenue, Price of AVAX 2015 to 2016
    6.7.4 Interviewee, Name and Contact
7 Technology Development Trend
 7.1 Manufacturing Process of Therapeutic Vaccines
 7.2 Analysis of Manufacturing Process
 7.3 Development Trend
8 Research Findings and Conclusion